Company News

Schering-Plough Issues Profit Warning

Author Image

By: TOM BRANNA

Editor

Schering-Plough, the leading player in the sun care market,warned that its first-quarter earnings would come in as much as 15% below last year’s profit of 42 cents a share. Analysts were looking for a profit of 48 cents a share. The company cited regulatory concerns about its drug manufacturing processes, which hampered sales. In addition, Schering-Plough said the FDA wouldn’t approve Clarinex, a new version of its popular antihistamine Claritin, until the manufacturing issues were r...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters